Atlas Trials

Cat Allergy

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cat Allergy

RecordFirmDate
Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge (NCT03838731)Regeneron Pharmaceuticals2019-02-12
Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients (NCT02959073)University of Zurich2016-09-01
A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy (NCT02311413)National Institute of Allergy and Infectious Diseases (NIAID)2015-03-09
Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy (NCT02237196)National Institute of Allergy and Infectious Diseases (NIAID)2015-03-03
Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients (NCT02399579)University of Zurich2015-03-01
Phase III Cat-PAD Follow-on Study (NCT02040844)Circassia Limited2014-02-01
An Optional Two Year Follow Up Study to Study CP005A (NCT01604018)Circassia Limited2012-02-01
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis (NCT01383603)Circassia Limited2011-10-01
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis (NCT01383590)Circassia Limited2011-10-01
Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy (NCT01292070)National Institute of Allergy and Infectious Diseases (NIAID)2011-03-01
Cat-PAD Follow on Study (NCT01272323)Circassia Limited2011-02-01
Cat-PAD Exposure Chamber Study (NCT01033344)Circassia Limited2010-01-01
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge (NCT01003301)Johns Hopkins University2009-10-01
Exposure Chamber Trial With Cat Immunotherapy (NCT00987909)ALK-Abelló A/S2009-09-01
Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma (NCT00867906)Circassia Limited2009-03-01
Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects (NCT00729508)Circassia Limited2008-08-01
Safety of Cat-PAD in Cat Allergic Subjects (NCT00685711)Circassia Limited2008-01-01

Track Cat Allergy automatically

Every clearance here is in the API, with alerts when new ones post.